These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6851402)

  • 21. Hemodynamic effects of intravenous prenalterol in patients on long-term digoxin therapy for congestive heart failure.
    Dahlström U; Karlsson E; Wranne B
    Eur Heart J; 1982 Aug; 3(4):331-8. PubMed ID: 7128622
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical results with prenalterol in patients with heart failure.
    Waagstein F; Reiz S; Ariniego R; Hjalmarson A
    Am Heart J; 1981 Sep; 102(3 Pt 2):548-54. PubMed ID: 7270401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prenalterol (CGP 7760 B), a new cardioselective beta 1-adrenoceptor-agonist (author's transl)].
    Piepenbrock S; Reichelt W; Zenz M; Seitz W; Sikalieh E
    Anaesthesist; 1981 Mar; 30(3):118-23. PubMed ID: 6111933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodynamic and cardiometabolic effects of prenalterol in patients with gram negative septic shock.
    Reiz S; Friedman A
    Acta Anaesthesiol Scand; 1980; 24(1):5-10. PubMed ID: 7376804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog.
    Manders WT; Vatner SF; Braunwald E
    J Pharmacol Exp Ther; 1980 Oct; 215(1):266-70. PubMed ID: 6109017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of prenalterol administered orally in patients with congestive heart failure.
    Hjalmarson A; Abelardo N; Caidahl K; Reyes C; Waagstein F; Wallentin I; Wikstrand J; Estrada-Yamamoto M
    Acta Med Scand Suppl; 1982; 659():201-20. PubMed ID: 6127890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.
    Glover DR; Wathen CG; Murray RG; Petch MC; Muir AL; Littler WA
    Br Heart J; 1985 Feb; 53(2):208-15. PubMed ID: 2857088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute haemodynamic effects of oral prenalterol in severe heart failure.
    Petch MC; Wisbey C; Ormerod O; Scott C; Goodfellow RM
    Br Heart J; 1984 Jul; 52(1):49-52. PubMed ID: 6146324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic assessment of prenalterol: a cardioselective beta agonist in patients with imparied left ventricular function.
    Klein W; Brandt D; Maurer E
    Clin Cardiol; 1981; 4(6):325-9. PubMed ID: 6120057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immediate haemodynamic and electrophysiological response to prenalterol during fixed rate pacing in patients with chronic ischaemic heart disease.
    Sire S; Amlie JP; Simonsen S
    Acta Pharmacol Toxicol (Copenh); 1986 Jan; 58(1):43-8. PubMed ID: 3953293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of prenalterol on central haemodynamics and VA/Q distribution early after open-heart surgery.
    Anjou-Lindskog E; Broman L; Holmgren A; Wedelin B
    Acta Anaesthesiol Scand; 1983 Apr; 27(2):142-8. PubMed ID: 6837248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of alprenolol on hemodynamic and metabolic responses to prolonged exercise in subjects with hypertension.
    Frisk-Holmberg M; Jorfeldt L; Juhlin-Dannfeldt A
    Clin Pharmacol Ther; 1977 Jun; 21(6):675-84. PubMed ID: 324693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenalterol as long-term therapy for chronic congestive heart failure. A randomized cross-over trial.
    Dahlström U; Areskog M; Wranne B; Karlsson E
    Acta Med Scand; 1984; 216(2):199-207. PubMed ID: 6149671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in coronary haemodynamics and myocardial metabolism at rest and during exercise after a cardiotonic drug (prenalterol) in patients with coronary artery disease.
    Westheim A; Bae E; Christensen CC; Fønstelien E; Grendahl H; Muller O
    Clin Physiol; 1988 Oct; 8(5):463-74. PubMed ID: 3191661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose metabolism during leg exercise in man.
    Wahren J; Felig P; Ahlborg G; Jorfeldt L
    J Clin Invest; 1971 Dec; 50(12):2715-25. PubMed ID: 5129319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of prenalterol and volume loading with dextran on haemodynamics and oxygen consumption in dogs during high epidural block with special reference to the splanchnic region.
    Greitz T; Andreen M; Irestedt L
    Acta Anaesthesiol Scand; 1985 Jan; 29(1):37-44. PubMed ID: 2579516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of beta-adrenoceptor blockade on leg blood flow and lactate release in man.
    Juhlin-Dannfelt A; Aström H
    Scand J Clin Lab Invest; 1979 Apr; 39(2):179-83. PubMed ID: 42966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ventilatory effects of selective beta 1-(prenalterol) or beta 2-(salbutamol) adrenoceptor agonism in man.
    Sorbini CA; Grassi V; Tantucci C; Corea L; Bentivoglio M; Verdecchia P; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):570-5. PubMed ID: 6150902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hemodynamic effects of a new beta-1 stimulating drug (prenalterol) in acute myocardial infarct in the open-chest pig].
    Branzi A; Binetti G; Specchia S; Magelli C; Zannoli R; Magnani B
    Cardiologia; 1982; 27(1):33-43. PubMed ID: 6152732
    [No Abstract]   [Full Text] [Related]  

  • 40. Intrinsic sympathomimetic activity of the partial agonist prenalterol in relation to beta adrenoceptor interaction in various tissues, in vitro.
    Mattsson H; Hedberg A; Carlsson E
    J Pharmacol Exp Ther; 1983 Mar; 224(3):654-61. PubMed ID: 6131123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.